Enero Group Limited (ASX:EGG)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	88	112	135	255	218	120
Market Cap Growth	-29.51%	-16.88%	-47.20%	17.39%	81.85%	-0.10%
Enterprise Value	63	88	149	219	181	104
Last Close Price	0.96	1.19	1.35	2.54	2.13	1.12
PE Ratio	-	-	2.39	10.06	-	11.17
Forward PE	10.32	7.08	4.96	8.99	9.20	8.59
PS Ratio	0.11	0.14	0.18	0.49	0.54	0.44
PB Ratio	0.50	0.69	0.62	1.64	1.65	0.96
P/TBV Ratio	11.44	15.28	-	7.86	21.40	8.85
P/FCF Ratio	5.29	4.27	2.23	5.36	4.17	4.04
P/OCF Ratio	4.99	4.16	2.19	5.23	4.09	3.86
EV/Sales Ratio	0.08	0.11	0.20	0.42	0.45	0.39
EV/EBITDA Ratio	1.93	2.50	1.91	3.42	3.88	4.02
EV/EBIT Ratio	2.77	2.96	2.06	3.58	4.13	4.63
EV/FCF Ratio	3.80	3.35	2.46	4.59	3.46	3.53
Debt / Equity Ratio	0.10	0.12	0.11	0.29	0.09	0.14
Debt / EBITDA Ratio	0.52	0.47	0.28	0.66	0.23	0.55
Debt / FCF Ratio	1.03	0.72	0.38	0.94	0.23	0.57
Asset Turnover	2.36	2.35	2.18	1.97	1.79	1.30
Inventory Turnover	-	181.37	146.66	108.64	113.25	66.66
Quick Ratio	1.03	1.05	1.16	1.76	1.13	1.21
Current Ratio	1.11	1.11	1.23	1.83	1.19	1.27
Return on Equity (ROE)	-14.66%	-19.45%	43.55%	29.38%	7.55%	11.18%
Return on Assets (ROA)	4.27%	5.41%	13.27%	14.40%	12.18%	6.77%
Return on Capital (ROIC)	6.89%	8.74%	20.37%	22.17%	19.14%	10.78%
Return on Capital Employed (ROCE)	12.00%	16.30%	26.60%	30.10%	29.50%	15.40%
Earnings Yield	-37.30%	-39.43%	41.89%	9.94%	-0.18%	8.95%
FCF Yield	18.92%	23.39%	44.80%	18.67%	24.00%	24.74%
Dividend Yield	3.11%	4.20%	8.18%	4.93%	7.01%	5.35%
Payout Ratio	-	-	21.34%	36.07%	-	44.21%
Buyback Yield / Dilution	1.72%	1.81%	-3.43%	-1.96%	-1.10%	-2.09%
Total Shareholder Return	4.72%	6.00%	4.74%	2.97%	5.91%	3.26%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.